Page last updated: 2024-11-07

spironolactone and Leukemia, Lymphoid

spironolactone has been researched along with Leukemia, Lymphoid in 2 studies

Spironolactone: A potassium sparing diuretic that acts by antagonism of aldosterone in the distal renal tubules. It is used mainly in the treatment of refractory edema in patients with congestive heart failure, nephrotic syndrome, or hepatic cirrhosis. Its effects on the endocrine system are utilized in the treatments of hirsutism and acne but they can lead to adverse effects. (From Martindale, The Extra Pharmacopoeia, 30th ed, p827)
spironolactone : A steroid lactone that is 17alpha-pregn-4-ene-21,17-carbolactone substituted by an oxo group at position 3 and an alpha-acetylsulfanyl group at position 7.

Leukemia, Lymphoid: Leukemia associated with HYPERPLASIA of the lymphoid tissues and increased numbers of circulating malignant LYMPHOCYTES and lymphoblasts.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dathan, JR1
Heyworth, MF1
MacIver, AG1
Taft, LI1

Other Studies

2 other studies available for spironolactone and Leukemia, Lymphoid

ArticleYear
Nephrotic syndrome in chronic lymphocytic leukaemia.
    British medical journal, 1974, Sep-14, Volume: 3, Issue:5932

    Topics: Aged; Basement Membrane; Biopsy; Blood Proteins; Bone Marrow; Chlorambucil; Complement System Protei

1974
Methotrexate induced hepatitis in childhood leukemia.
    Israel journal of medical sciences, 1965, Volume: 1, Issue:4

    Topics: Aminopterin; Biopsy; Chemical and Drug Induced Liver Injury; Child; Child, Preschool; Female; Humans

1965